|Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent|
J Linnen, J Wages, ZY Zhang-Keck, KE Fry, KZ Krawczynski, H Alter, ...
Science 271 (5248), 505-508, 1996
|Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection|
WF Carman, S Hadziyannis, MJ McGarvey, MR Jacyna, P Karayiannis, ...
The Lancet 334 (8663), 588-591, 1989
|Vaccine-induced escape mutant of hepatitis B virus|
WF Carman, P Karayiannis, J Waters, HC Thomas, AR Zanetti, G Manzillo, ...
The lancet 336 (8711), 325-329, 1990
|Natural history of chronic hepatitis B virus infection in Taiwan: studies of hepatitis B virus DNA in serum|
CM Chu, P Karayiannis, MJF Fowler, J Monjardino, YF Liaw, HC Thomas
Hepatology 5 (3), 431-434, 1985
|Which patients with chronic hepatitis B virus infection will respond to α‐interferon therapy? A statistical analysis of predictive factors|
MG Brook, P Karayiannis, HC Thomas
Hepatology 10 (5), 761-763, 1989
|Identification of unique hepatitis C virus quasispecies in the central nervous system and comparative analysis of internal translational efficiency of brain, liver, and serum …|
DM Forton, P Karayiannis, N Mahmud, SD Taylor-Robinson, HC Thomas
Journal of virology 78 (10), 5170-5183, 2004
|Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigen–negative Chinese carriers|
J Hou, Z Wang, J Cheng, Y Lin, GKK Lau, J Sun, F Zhou, J Waters, ...
Hepatology 34 (5), 1027-1034, 2001
|Diminished responsiveness of male homosexual chronic hepatitis B virus carriers with HTLV‐III antibodies to recombinant α‐interferon|
JA McDonald, L Caruso, P Karayiannis, LJ Scully, JRW Harris, GE Forster, ...
Hepatology 7 (4), 719-723, 1987
|Delayed anti-HCV antibody response in HIV-positive men acutely infected with HCV|
EC Thomson, E Nastouli, J Main, P Karayiannis, J Eliahoo, D Muir, ...
AIDS (London, England) 23 (1), 89, 2009
|High risk of non‐A non‐B hepatitis after a first exposure to volunteer or commercial clotting factor concentrates: effects of prophylactic immune serum globulin|
PBA Kernoff, CA Lee, P Karayiannis, HC Thomas
British journal of haematology 60 (3), 469-479, 1985
|Transfer of a functioning humoral immune system in transplantation of T-lymphocyte-depleted bone marrow|
JZ Wimperis, HG Prentice, P Karayiannis, MK Brenner, JE Reittie, ...
The Lancet 327 (8477), 339-343, 1986
|Predicting spontaneous clearance of acute hepatitis C virus in a large cohort of HIV-1-infected men|
EC Thomson, VM Fleming, J Main, P Klenerman, J Weber, J Eliahoo, ...
Gut 60 (6), 837-845, 2011
|A double blind, placebo‐controlled study to assess the effect of famciclovir on virus replication in patients with chronic hepatitis B virus infection|
J Main, JL Brown, C Howells, R Galassini, M Crossey, P Karayiannis, ...
Journal of viral hepatitis 3 (4), 211-215, 1996
|Effect of variation in the common “a” determinant on the antigenicity of hepatitis B surface antigen|
S Seddigh‐Tonekaboni, JA Waters, S Jeffers, R Gehrke, B Ofenloch, ...
Journal of medical virology 60 (2), 113-121, 2000
|Hepatitis B virus: old, new and future approaches to antiviral treatment|
Journal of Antimicrobial Chemotherapy 51 (4), 761-785, 2003
|Effect of basal core promoter and pre-core mutations on hepatitis B virus replication|
S Jammeh, F Tavner, R Watson, HC Thomas, P Karayiannis
Journal of General Virology 89 (4), 901-909, 2008
|A unique insertion in the S gene of surface antigen–negative hepatitis B virus Chinese carriers|
J Hou, P Karayiannis, J Waters, K Luo, C Liang, HC Thomas
Hepatology 21 (2), 273-278, 1995
|Contribution of low level HBV replication to continuing inflammatory activity in patients with anti-HBe positive chronic hepatitis B virus infection.|
AS Lok, SJ Hadziyannis, IV Weller, MG Karvountzis, J Monjardino, ...
Gut 25 (11), 1283-1287, 1984
|Detection of serum HBV-DNA by molecular hybridisation: correlation with HBeAg/anti-HBe status, racial origin, liver histology and hepatocellular carcinoma|
P Karayiannis, MJF Fowler, ASF Lok, C Greenfield, J Monjardino, ...
Journal of Hepatology 1 (2), 99-106, 1985
|Randomised controlled trial of interferon alfa 2A (rbe)(Roferon-A) for the treatment of chronic hepatitis B virus (HBV) infection: factors that influence response.|
MG Brook, JA McDonald, P Karayiannis, L Caruso, G Forster, JR Harris, ...
Gut 30 (8), 1116-1122, 1989